Hydrochlorothiazide Imports from BANGLADESH to India — Trade Data & Analysis

TransData Nexus

Hydrochlorothiazide

India Pharmaceutical Trade Intelligence

$406.8M403 Suppliers149 CountriesHS 30049079

ExportsIndia → UNITED STATES63.6%India → CANADA14.9%

ImportsISRAEL → India$15.4M ITALY → India$69.2K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Hydrochlorothiazide Imports from BANGLADESH to India (2026) — $34 USD, 4 Shipments, Top Suppliers | TransData Nexus | TransData Nexus

Who Supplies Hydrochlorothiazide to India from BANGLADESH

India's hydrochlorothiazide imports from BANGLADESH total $34 across 4 shipments from 2 foreign suppliers. SQUARE PHARMACEUTICAL PLC. leads with $22 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include LAMBDA THERAPEUTIC RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for hydrochlorothiazide — a concentrated sourcing relationship with select suppliers from BANGLADESH.

Source: Indian Customs (DGFT) Import Records · TransData NexusUpdated February 2026

Top foreign suppliers (BANGLADESH) — Ranked by import value

SQUARE PHARMACEUTICAL PLC. is the leading Hydrochlorothiazide supplier from BANGLADESH to India, with import value of $22 across 2 shipments. The top 5 suppliers — SQUARE PHARMACEUTICAL PLC., INCEPTA PHARMACEUTICALS LTD. — collectively account for 100.0% of total import value from this origin.

Top foreign suppliers (BANGLADESH)

Ranked by import value (USD) · Indian Customs (DGFT) data

Feb 2026

Top Hydrochlorothiazide suppliers from BANGLADESH to India — ranked by import value (USD). 2 suppliers. Indian Customs (DGFT) data compiled by TransData Nexus.
#	Supplier	Value (USD)	Shipments	Share
1	SQUARE PHARMACEUTICAL PLC.	$22	2	64.3%

Top Indian buyers (importing from BANGLADESH)

Ranked by import value (USD)

Top Indian buyers of Hydrochlorothiazide from BANGLADESH — ranked by import value
#	Buyer	Value (USD)	Shipments	Share
1	LAMBDA THERAPEUTIC RESEARCH LIMITED	$22	2	64.3%
2	SPINOS LIFE SCIENCE AND RESEARCH PRIVATE LIMITED	$12	2	35.7%

Frequently Asked Questions — Hydrochlorothiazide Imports from BANGLADESH

Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus

QWho are the top Hydrochlorothiazide suppliers from BANGLADESH to India?

The top Hydrochlorothiazide suppliers from BANGLADESH to India include SQUARE PHARMACEUTICAL PLC., INCEPTA PHARMACEUTICALS LTD.. The leading supplier is SQUARE PHARMACEUTICAL PLC. with import value of $22 USD across 2 shipments. India imported Hydrochlorothiazide worth $34 USD from BANGLADESH in total across 4 shipments.

QHow much Hydrochlorothiazide does India import from BANGLADESH?

India imported Hydrochlorothiazide worth $34 USD from BANGLADESH across 4 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.

QWho are the main Indian buyers of Hydrochlorothiazide from BANGLADESH?

The main Indian buyers of Hydrochlorothiazide sourced from BANGLADESH include LAMBDA THERAPEUTIC RESEARCH LIMITED, SPINOS LIFE SCIENCE AND RESEARCH PRIVATE LIMITED. The largest buyer is LAMBDA THERAPEUTIC RESEARCH LIMITED with $22 in imports across 2 shipments.

QWhat is the total value of Hydrochlorothiazide imports from BANGLADESH to India?

The total value of Hydrochlorothiazide imports from BANGLADESH to India is $34 USD, across 4 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.